Qi, F., Hu, X., Liu, Y., Wang, Z., Duan, J., Wang, J., & Dong, M. (2019). First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China. Chin J Cancer Res.
シカゴスタイル引用形Qi, Fei, Xingsheng Hu, Yutao Liu, Zhijie Wang, Jianchun Duan, Jie Wang, , Mei Dong. "First-line Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab in Non-squamous Non-small Cell Lung Cancer: A Real-world Propensity Score-matched Study in China." Chin J Cancer Res 2019.
MLA引用形式Qi, Fei, et al. "First-line Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab in Non-squamous Non-small Cell Lung Cancer: A Real-world Propensity Score-matched Study in China." Chin J Cancer Res 2019.